Vita Life Sciences Limited
ASX:VLS.AX
2.1 (AUD) • At close November 8, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) AUD.
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
| 74.161 | 66.886 | 57.101 | 46.481 | 42.452 | 41.151 | 37.738 | 37.858 | 38.584 | 36.58 | 35.411 | 30.191 | 24.267 | 20.191 | 17.015 | 14.376 | 11.87 |
Cost of Revenue
| 31.557 | 27.146 | 22.293 | 17.209 | 14.555 | 13.51 | 12.122 | 11.7 | 11.43 | 10.538 | 11.366 | 10.674 | 8.549 | 7.858 | 6.751 | 5.792 | 5.059 |
Gross Profit
| 42.604 | 39.74 | 34.808 | 29.272 | 27.897 | 27.641 | 25.616 | 26.158 | 27.154 | 26.042 | 24.045 | 19.517 | 15.718 | 12.333 | 10.264 | 8.584 | 6.811 |
Gross Profit Ratio
| 0.574 | 0.594 | 0.61 | 0.63 | 0.657 | 0.672 | 0.679 | 0.691 | 0.704 | 0.712 | 0.679 | 0.646 | 0.648 | 0.611 | 0.603 | 0.597 | 0.574 |
Reseach & Development Expenses
| 0.017 | 0.004 | 0.009 | 0.008 | 0.072 | 0.015 | 0.014 | 0.02 | 0.016 | 0.014 | 0.015 | 0 | 0 | 0 | 0 | 0 | 0 |
General & Administrative Expenses
| 18.058 | 16.687 | 14.651 | 14.012 | 14.669 | 13.475 | 11.774 | 11.858 | 12.891 | 11.923 | 11.879 | 10.511 | 9.144 | 7.472 | 5.817 | 5.048 | 4.419 |
Selling & Marketing Expenses
| 11.366 | 10.416 | 7.565 | 6.163 | 7.375 | 6.737 | 6.093 | 6.146 | 6.43 | 5.621 | 5.075 | 4.848 | 3.876 | 2.909 | 2.574 | 2.377 | 1.751 |
SG&A
| 30.389 | 27.103 | 22.216 | 20.175 | 22.044 | 20.212 | 17.867 | 18.004 | 19.321 | 17.544 | 16.954 | 15.359 | 13.02 | 10.381 | 8.391 | 7.425 | 6.17 |
Other Expenses
| 0.152 | 1.918 | 1.585 | 1.552 | 1.746 | -1.779 | 0.001 | 0.242 | 0.037 | 0.171 | -0.016 | 0.081 | 0.022 | 6.001 | 0.162 | 1.036 | 0.504 |
Operating Expenses
| 30.389 | 29.021 | 23.801 | 21.727 | 23.79 | 21.565 | 20.92 | 20.707 | 21.079 | 19.325 | 18.486 | 16.73 | 14.23 | 13.441 | 10.448 | 8.969 | 7.228 |
Operating Income
| 12.215 | 10.772 | 11.306 | 8.324 | 4.574 | 4.429 | 4.812 | 5.805 | 6.26 | 7.059 | 5.652 | 2.992 | 1.58 | 4.875 | -0.155 | 0.489 | 0.112 |
Operating Income Ratio
| 0.165 | 0.161 | 0.198 | 0.179 | 0.108 | 0.108 | 0.128 | 0.153 | 0.162 | 0.193 | 0.16 | 0.099 | 0.065 | 0.241 | -0.009 | 0.034 | 0.009 |
Total Other Income Expenses Net
| 0.236 | -0.034 | -0.105 | -0.166 | -0.146 | -1.725 | 0.002 | 0.251 | 0.02 | 0.165 | -0.048 | 0.078 | 0.001 | 6.013 | 0.076 | 0.85 | 0.397 |
Income Before Tax
| 12.451 | 10.738 | 11.201 | 8.158 | 4.428 | 4.33 | 4.676 | 5.637 | 6.002 | 6.925 | 5.516 | 2.841 | 1.403 | 4.626 | -0.333 | 0.306 | -0.324 |
Income Before Tax Ratio
| 0.168 | 0.161 | 0.196 | 0.176 | 0.104 | 0.105 | 0.124 | 0.149 | 0.156 | 0.189 | 0.156 | 0.094 | 0.058 | 0.229 | -0.02 | 0.021 | -0.027 |
Income Tax Expense
| 3.373 | 3.397 | 2.954 | 2.296 | 1.334 | 1.897 | 1.82 | 2.301 | 1.651 | -0.359 | 0.77 | 0.525 | 0.19 | 0.167 | -0.005 | -0.048 | -0.12 |
Net Income
| 9.08 | 7.084 | 8.292 | 6.094 | 3.136 | 2.439 | 2.863 | 3.343 | 4.391 | 7.28 | 4.748 | 2.367 | 1.213 | 4.46 | -0.328 | 0.353 | -0.253 |
Net Income Ratio
| 0.122 | 0.106 | 0.145 | 0.131 | 0.074 | 0.059 | 0.076 | 0.088 | 0.114 | 0.199 | 0.134 | 0.078 | 0.05 | 0.221 | -0.019 | 0.025 | -0.021 |
EPS
| 0.17 | 0.13 | 0.16 | 0.12 | 0.057 | 0.044 | 0.052 | 0.061 | 0.079 | 0.13 | 0.085 | 0.044 | 0.021 | 0.082 | -0.007 | 0.007 | -0.01 |
EPS Diluted
| 0.17 | 0.13 | 0.16 | 0.12 | 0.057 | 0.044 | 0.052 | 0.059 | 0.077 | 0.13 | 0.084 | 0.041 | 0.021 | 0.082 | -0.007 | 0.007 | -0.01 |
EBITDA
| 12.727 | 11.371 | 11.715 | 8.877 | 5.178 | 4.832 | 5.149 | 6.071 | 6.374 | 7.177 | 5.765 | 3.086 | 1.673 | 4.993 | -0.008 | 0.651 | 0.246 |
EBITDA Ratio
| 0.172 | 0.17 | 0.205 | 0.191 | 0.122 | 0.117 | 0.136 | 0.16 | 0.165 | 0.196 | 0.163 | 0.102 | 0.069 | 0.247 | -0 | 0.045 | 0.021 |